Search

Mark Kalinich

from Cambridge, MA
Age ~33
Get Report
Also known as:
Mark H
Related to:
Jennifer Miller Baldridge, 55Dan MillerKevin James Mika, 63Peter Kalinich, 71Kathy J Kalinich, 65Michael Kalinich, 30
Connected to:
Charlene L Kalinich, 63Igor Kalinichenko, 60John S Kalinich, 71Aliaksandr N Kalinin, 42Anastasia V Kalinina, 36Dmitri Kalinin, 43Elena Kalinina, 62Jessica J Kalinin, 31Kira Kalinin, 56Margarita I Kalinina, 67

Mark Kalinich Phones & Addresses

  • Cambridge, MA
  • Boston, MA
  • 12143 Northcote Ave, Saint John, IN 46373 (219) 365-4374

Work

Company: Langer laboratories Jan 2010 Address: Koch Institute for Integrative Cancer Research Position: Undergraduate researcher

Education

Degree: Bachelor of Science (BS) School / High School: MIT 2009 to 2013 Specialities: Chemical-Biological Engineering

Skills

Transfection • Cell Culture • Data Analysis • Molecular Biology • Drug Delivery • Biochemistry • Pcr • Biomaterials • Matlab • Tissue Engineering • Fluorescence Microscopy • Gel Electrophoresis • Flow Cytometry • Biotechnology • Western Blotting • Biomedical Engineering • Lifesciences • Tissue Culture • Nanoparticles • Protein Purification • Immunohistochemistry • In Vitro • Sds Page • Elisa • Hplc • Mathematical Modeling

Languages

English

Ranks

Certificate: Data Manipulation In R With Dplyr

Industries

Higher Education

Resumes

Resumes

Mark Kalinich Photo 1

M.d And Ph.d Candidate

View page
Location:
Cambridge, MA
Industry:
Higher Education
Work:
Langer Laboratories - Koch Institute for Integrative Cancer Research since Jan 2010
Undergraduate Researcher
Cardinal Scholars - Cambridge, MA since Jan 2012
Private Tutor
Education:
MIT 2009 - 2013
Bachelor of Science (BS), Chemical-Biological Engineering
Skills:
Transfection
Cell Culture
Data Analysis
Molecular Biology
Drug Delivery
Biochemistry
Pcr
Biomaterials
Matlab
Tissue Engineering
Fluorescence Microscopy
Gel Electrophoresis
Flow Cytometry
Biotechnology
Western Blotting
Biomedical Engineering
Lifesciences
Tissue Culture
Nanoparticles
Protein Purification
Immunohistochemistry
In Vitro
Sds Page
Elisa
Hplc
Mathematical Modeling
Languages:
English
Certifications:
Data Manipulation In R With Dplyr

Publications

Us Patents

Digital Analysis Of Blood Samples To Determine Efficacy Of Cancer Therapies For Specific Cancers

View page
US Patent:
20220364185, Nov 17, 2022
Filed:
May 27, 2022
Appl. No.:
17/826834
Inventors:
- Boston MA, US
Shyamala Maheswaran - Lexington MA, US
Tanya Todorova - Malden MA, US
Mark Kalinich - Cambridge MA, US
David Tomoaki Miyamoto - Wellesley MA, US
Xin Hong - Malden MA, US
International Classification:
C12Q 1/6886
Abstract:
This disclosure relates to new assay methods for analysis of RNA, e.g., from circulating tumor cells (CTCs), tumor-specific exosomes, or tumor-specific cell-free RNA, in a subject's blood sample to determine an expression level of one or more lineage markers in the blood sample, wherein the expression level of a specific one or more lineage markers is predictive of progression-free survival and overall survival for a specific anti-cancer treatment regimen in that subject.

User Interface Controls For Visual Software Modification

View page
US Patent:
20230019933, Jan 19, 2023
Filed:
Jul 14, 2022
Appl. No.:
17/812588
Inventors:
- Cambridge MA, US
Jonathan Wang - Cambridge MA, US
Mark Kalinich - Cambridge MA, US
International Classification:
G06F 8/38
G06F 8/20
G06F 3/0484
Abstract:
Techniques for visual software development are disclosed, including: generating, by a visual code editor, a data model of code elements in a set of source code; based on the data model, generating an adjustable graphical user interface (GUI) control corresponding to a subset of the set of source code; presenting the adjustable GUI control in a GUI of the visual code editor; and responsive to user input in the GUI to adjust the adjustable GUI control, modifying the set of source code according to the user input and executing the modified set of source code.

Digital Analysis Of Blood Samples To Determine Efficacy Of Cancer Therapies For Specific Cancers

View page
US Patent:
20190391134, Dec 26, 2019
Filed:
Oct 27, 2017
Appl. No.:
16/344557
Inventors:
- Boston MA, US
Shyamala Maheswaran - Lexington MA, US
Tanya Todorova - Malden MA, US
Mark Kalinich - Cambridge MA, US
David Tomoaki Miyamoto - Wellesley MA, US
Xin Hong - Medford MA, US
International Classification:
G01N 33/50
C12Q 1/6886
Abstract:
This disclosure relates to new assay methods for analysis of RNA, e.g., from circulating tumor cells (CTCs), tumor-specific exosomes, or tumor-specific cell-free RNA, in a subject's blood sample to determine an expression level of one or more lineage markers in the blood sample, wherein the expression level of a specific one or more lineage markers is predictive of progression-free survival and overall survival for a specific anti-cancer treatment regimen in that subject.
Control profile
Mark Kalinich from Cambridge, MA, age ~33 Get Report